decrease renal function 예문

예문

예문 더보기:   1  2

1. Unlike spironolactone, bicalutamide has no antimineralocorticoid activity, and for this reason, has no risk of hyperkalemia ( which can, rarely / in severe cases, result in hospitalization or death ) or other antimineralocorticoid side effects such as urinary frequency, dehydration, hypotension, hyponatremia, metabolic acidosis, or decreased renal function that may occur with spironolactone treatment.